Abstract

Topiramate 5 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2020 - Volume 24, Number 2

Page(s): 138

Download in electronic PDF format for $75
  • Topiramate 5 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Topiramate 5 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • topiramate
  • Topamax
  • formulation
  • stability
  • storage temperature
  • seizure disorders
  • children
  • Lennox-Gastaut syndrome
  • migraine

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • PAIN MANAGEMENT
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2020
Pg. 138
Topiramate 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2017
Pg. 339-346
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
Author(s): de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Nov/Dec 2009
Pg. 560
Topiramate 6-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 130
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 135
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 281-287
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Author(s): Newton David W
Nov/Dec 2021
Pg. 482-485
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Author(s): Harris Kylie, Wright Edward
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 148
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Mar/Apr 2020
Pg. 136
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 137
Terbinafine 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 133
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 134
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 131
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C